文献速递心外重症与机械循环支持瓣膜外科

VA-ECLS桥接至同期心肾移植:新心脏分配政策时代的全国结局

Bridge to simultaneous heart-kidney transplantation via extracorporeal life support: National outcomes in the new heart allocation policy era.
PubMed 文献 · J Heart Lung Transplant · 2024-09-06

结果显示VA-ECLS组出院生存率(76.0% vs 92.7%)和2年移植后生存率(71.7% vs 83.0%)更低,2年心脏移植物衰竭累积发生率更高(10.0% vs 2.7%),但肾脏结局相似。多变量分析显示VA-ECLS独立关联2年移植后死亡(HR 3.40)和心脏移植物衰竭(SHR 8.51)。

要点

  • VA-ECLS桥接SHK患者出院生存率(76.0%)和2年生存率(71.7%)显著低于非桥接者。
  • VA-ECLS组2年心脏移植物衰竭累积发生率更高(10.0% vs 2.7%,p=0.002)。
  • 两组2年慢性透析和肾移植物衰竭累积发生率相似。

核心结论

  • 在新分配政策下,VA-ECLS桥接至SHK的患者较非ECLS桥接者早期死亡和心脏移植物衰竭风险更高,但肾脏结局相似。

研究设计与样本

  • 回顾性队列研究,基于UNOS数据库纳入774例成人SHK受者,比较VA-ECLS桥接组(n=50)与非桥接组(n=724)。

主要发现

  • VA-ECLS组更年轻(50.5 vs 58.0岁,p=0.007),移植时eGFR更高(47.6 vs 30.1,p<0.001),等待名单时间更短(7.0 vs 33.5天,p<0.001)。
  • VA-ECLS组临时透析率更高(56.0% vs 28.0%,p<0.001),但2年慢性透析累积发生率(7.5% vs 5.4%,p=0.800)和肾移植物衰竭累积发生率(12.0% vs 8.1%,p=0.500)相似。
  • VA-ECLS组出院生存率更低(76.0% vs 92.7%,p<0.001),2年移植后生存率更低(71.7% vs 83.0%,p=0.004),2年心脏移植物衰竭累积发生率更高(10.0% vs 2.7%,p=0.002)。
  • 多变量分析显示VA-ECLS独立关联2年移植后死亡(HR 3.40,95%CI 1.66-6.96,p=0.001)和心脏移植物衰竭(SHR 8.51,95%CI 2.77-26.09,p<0.001)。

临床怎么用

  • 在考虑VA-ECLS桥接至SHK时,应充分评估患者术后早期死亡和心脏移植物衰竭的高风险。
  • VA-ECLS桥接SHK患者的肾脏结局与非ECLS桥接者相似,但心脏结局更差,需加强术后心脏监测和管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since United Network for Organ Sharing (UNOS) revised their heart allocation policy in 2018, usage of veno-arterial extracorporeal life support (VA-ECLS) has dramatically increased as a bridge to transplant. This study investigated outcomes of VA-ECLS patients bridged to simultaneous heart-kidney transplant (SHK) in the new policy era. METHODS: This study included 774 adult patients from the UNOS database who received SHK between 10/18/18 and 12/31/21 and compared patients bridged to transplant on VA-ECLS (n = 50) with those not bridged (n = 724). RESULTS: At baseline, SHK recipients bridged from VA-ECLS were younger (50.5 vs 58.0 years, p = 0.007), had higher estimated glomerular filtration rate (eGFR) at time of transplant (47.6 vs 30.1, p < 0.001), and spent fewer days on the waitlist (7.0 vs 33.5 days, p < 0.001). In the perioperative period, VA-ECLS was associated with higher rates of temporary dialysis (56.0% vs 28.0%, p < 0.001) but similar 2-year cumulative incidence of chronic dialysis (7.5% vs 5.4%, p = 0.800) and renal allograft failure (12.0% vs 8.1%, p = 0.500) compared to non-ECLS cohort. However, VA-ECLS patients had decreased survival to discharge (76.0% vs 92.7%, p < 0.001) and 2-year post-transplant survival (71.7% vs 83.0%, p = 0.004), as well as greater 2-year cumulative incidence of cardiac allograft failure (10.0% vs 2.7%, p = 0.002). Multivariable analyses found VA-ECLS at time of transplant to be independently associated with 2-year post-transplant mortality (HR [95% CI]: 3.40 [1.66-6.96], p = 0.001) and cardiac allograft failure (sub-distribution hazard ratio [SHR] [95% CI]: 8.51 [2.77-26.09], p < 0.001). CONCLUSION: Under the new allocation policy, patients bridged to SHK from VA-ECLS displayed greater early mortality and cardiac allograft failure but similar renal outcomes compared to non-ECLS counterparts.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Feng I, Kurlansky PA, Zhao Y, et al. Bridge to simultaneous heart-kidney transplantation via extracorporeal life support: National outcomes in the new heart allocation policy era. J Heart Lung Transplant. 2024. PMID: 39245425. doi:10.1016/j.healun.2024.08.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。